BPMC

Blueprint Medicines
BPMC

Overview Fund Activity
Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

304 hedge funds and large institutions have $7.15B invested in Blueprint Medicines in 2024 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 114 increasing their positions, 100 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
304
Holders Change
+22
Holders Change %
+7.8%
% of All Funds
4.42%
Holding in Top 10
8
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+166.67%
% of All Funds
0.12%
New
50
Increased
114
Reduced
100
Closed
25
Calls
$295M
Puts
$140M
Net Calls
+$155M
Net Calls Change
+$121M

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$67.6M
2
1832 Asset Management
2
1832 Asset Management
Ontario, Canada
$54.2M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$705M
4
Holocene Advisors
4
Holocene Advisors
New York
$102M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$54.1M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$349M
2
Pictet Asset Management
2
Pictet Asset Management
Switzerland
$122M
3
Morgan Stanley
3
Morgan Stanley
New York
$45.4M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$633M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$521M
Name Holding Trade Value Shares
Change 		Shares
Change %
HCM
326
Hollencrest Capital Management
California
– -$2.85K -30 Closed
RS
327
Rakuten Securities
Japan
– -$474 -5 Closed
FGAM
328
Financial Gravity Asset Management
Texas
– -$362 -4 Closed
10 11 12 13
14